Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine.

about

Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine.

Item

http://www.wikidata.org/entity/Q55303632

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Immunological responses follow ...... quadrivalent HCV VLP vaccine.

@en

Immunological responses follow ...... quadrivalent HCV VLP vaccine.

@nl

type

Item

label

Immunological responses follow ...... quadrivalent HCV VLP vaccine.

@en

Immunological responses follow ...... quadrivalent HCV VLP vaccine.

@nl

prefLabel

Immunological responses follow ...... quadrivalent HCV VLP vaccine.

@en

Immunological responses follow ...... quadrivalent HCV VLP vaccine.

@nl

P1476

Immunological responses follow ...... a quadrivalent HCV VLP vaccine

@en

P2093

B Grubor-Bauk

http://www.w3.org/2001/XMLSchema#string

D Christiansen

http://www.w3.org/2001/XMLSchema#string

E J Gowans

http://www.w3.org/2001/XMLSchema#string

I Boo

http://www.w3.org/2001/XMLSchema#string

J Torresi

http://www.w3.org/2001/XMLSchema#string

L Earnest-Silveira

http://www.w3.org/2001/XMLSchema#string

S K H Foung

http://www.w3.org/2001/XMLSchema#string

Z Y Keck

http://www.w3.org/2001/XMLSchema#string

P2860

Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection.

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies

Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes

Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus

Hepatitis C Virus E2 Envelope Glycoprotein Core Structure

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans

Impaired dendritic cell maturation in response to pandemic H1N109 influenza virus.

Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture

P304

6483

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-24762-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29691437

http://www.w3.org/2001/XMLSchema#string

P921

immunology

P932

5915487

http://www.w3.org/2001/XMLSchema#string